keted products as well as for the discovery and development of new products. Discovery or identification of new product candidates cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock.
Amgen Inc.Condensed Consolidated Statements of Income - GAAP(In millions, except per share data)(Unaudited)Three months endedSix months ended June 30, June 30, 2012201120122011Revenues:Product sales
$ 4,200$ 3,893$ 8,101$ 7,511Other revenues
27766424154Total revenues
4,4773,9598,5257,665Operating expenses:Cost of sales (excludes amortization of certainacquired intangible assets presented below)
6826021,3611,166Research and development
8268191,5621,555Selling, general and administrative
1,2281,1302,3042,153Amortization of certain acquired intangible assets
7373147147Other
7938519Total operating expenses
2,8882,6275,4595,040Operating income
1,5891,3323,0662,625Interest expense, net
256122491257Interest and other income, net
124129248277Income before income taxes
1,4571,3392,8232,645Provision for income taxes
191169373350Net income
$ 1,266$ 1,170$ 2,450$ 2,295Earnings per share:Basic
$
.63$
.26$
3.13$
2.47Diluted
$
.61$
.25$
3.09$
2.45Average shares used in calculationof earnings per share:Basic
776927783930Diluted
785935792938
Amgen Inc.Product S
'/>"/>
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine technology :1.
Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler2.
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 20123.
Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call4.
The Female Health Company Reports Second Quarter Operating Results5.
Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT6.
Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 20127.
Landauer, Inc. Reports Fiscal 2012 Second Quarter Results8.
Elsevier Launches Second Annual Mosbys Superheroes of Nursing Contest During Nurses Week 20129.
BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti10.
HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine11.
Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters